Lindsay Androski - 01 Jul 2022 Form 3 Insider Report for Eloxx Pharmaceuticals, Inc.

Role: Director
Signature: /s/ Sumit Aggarwal, as Attorney-in-Fact for Lindsay Androski
Issuer symbol: N/A
Transactions as of: 01 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 06 Jul 2022, 21:49:23 UTC
Next filing: 31 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney